uric acid has been researched along with B16 Melanoma in 2 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we used a mouse model of hyperuricemia, the Urahplt2/plt2 (PLT2) mouse, to investigate the effect of high uric acid levels on anti-tumor immune responses and tumor growth." | 3.88 | Hyperuricaemic UrahPlt2/Plt2 mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C. ( Baey, C; Harper, JL; Ronchese, F; Yang, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baey, C | 1 |
| Yang, J | 2 |
| Ronchese, F | 2 |
| Harper, JL | 2 |
| Kuhn, S | 1 |
| Hyde, EJ | 1 |
| Rich, FJ | 1 |
| Kirman, JR | 1 |
2 other studies available for uric acid and B16 Melanoma
| Article | Year |
|---|---|
Hyperuricaemic UrahPlt2/Plt2 mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C.
Topics: Amidohydrolases; Animals; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Prolife | 2018 |
Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Animals; Biological Therapy; Carcinoma; CD8-Positive T-Ly | 2013 |